Why Many Kanna Products Fall Short

Kanna is a botanical material, and its alkaloid content can vary depending on plant chemotype, cultivation conditions, and processing methods. Without standardization, the labeled milligram amount of “kanna” does not reliably reflect the quantity of active alkaloids present.

When a product does not disclose its alkaloid percentage, it becomes difficult to meaningfully compare that formulation to published human research.

Quality Standards That Matter

1. Alkaloid Standardization on the Label

Look for a clearly stated extract dose and alkaloid percentage, such as: “30 mg Sceletium tortuosum extract, standardized to X% total alkaloids.”

Milligram weight alone does not reliably reflect active alkaloid content without standardization.

2. Third-Party Certificate of Analysis (COA)

A batch-specific COA should confirm alkaloid content and screen for heavy metals, pesticides, and microbial contamination. Independent third-party testing supports transparency and quality control.

3. cGMP-Compliant Manufacturing

Production in a facility that follows current Good Manufacturing Practices (cGMP) helps support consistency, documentation, and quality oversight.

4. Transparent Formulation Oversight

Disclosure of qualified professional involvement in formulation may support appropriate dosing decisions and product integrity.

5. Transparent Sourcing

Clear disclosure of botanical origin and cultivation practices supports traceability and authenticity.

6. No Undisclosed Proprietary Blends

Be cautious of proprietary blends that obscure the exact amount of kanna provided, making it difficult to assess potency.

How SoulBloom Approaches Quality

SoulBloom is formulated with the following quality considerations:

• 25 mg standardized Sceletium tortuosum extract per serving (5% total alkaloids)
• Batch-specific third-party Certificate of Analysis (COA) available
• Manufactured in a cGMP-compliant facility
• Transparent formulation oversight
• Disclosed South African botanical sourcing
• Designed for sublingual use to support efficient absorption

Potential Red Flags

Be cautious of products that:

• Do not disclose alkaloid percentage
• Do not provide a batch-specific third-party COA
• Hide kanna within a proprietary blend
• Make explicit medical claims (e.g., “treats anxiety” or “cures depression”)
• Provide minimal transparency about sourcing or manufacturing

FAQ

Is more expensive always better?

What does “full-spectrum” mean?

How do I read a COA?

• The batch number matches your product
• Alkaloid content aligns with the labeled claim
• Heavy metals and contaminants are within acceptable limits
• The testing laboratory is identified
• The report is recent and batch-specific

What Is Kanna?

Historical accounts describe the Khoisan peoples chewing fermented kanna during long hunts and communal rituals, with reported effects on alertness, appetite, and social connectedness.

Today, kanna is formulated as a standardized extract in gummies, tinctures, and capsules. Unlike many botanicals marketed for mood support, kanna has both documented traditional use and small randomized controlled human trials evaluating its neurobiological effects.

What differentiates kanna pharmacologically is its dual activity. Standardized extracts have demonstrated serotonin transporter modulation alongside phosphodiesterase-4 inhibition in laboratory models, a combination that may help explain its distinctive subjective profile in adults.

The Science: How Kanna Works

Mechanism 1: Serotonin Transporter Modulation

Standardized kanna extracts contain alkaloids such as mesembrine and mesembrenone that demonstrate activity at the serotonin transporter (SERT) in laboratory models. By inhibiting serotonin reuptake in vitro, these compounds may prolong synaptic serotonin signaling.

This pathway is also targeted by certain prescription medications, though kanna extracts differ significantly in potency, pharmacokinetics, and intended use.

At typical supplemental doses, effects are transient rather than cumulative.

In healthy adults, reported subjective responses may include improved mood stability, decreased stress reactivity, greater social comfort, and a sense of emotional openness.

Mechanism 2: PDE4 Activity

Mesembrenone has demonstrated inhibitory activity at phosphodiesterase-4 (PDE4) in laboratory models. PDE4 plays a regulatory role in intracellular cyclic AMP (cAMP) signaling, a pathway involved in attention, emotional regulation, and higher-order cognitive processing.

In broader neuropharmacology, PDE4 modulation has been studied for its effects on cognitive flexibility and executive control. While human data specific to kanna remain limited, this dual interaction with serotonin transport and cAMP signaling may help explain the distinct subjective profile reported by some adults.

Rather than acting as a stimulant, kanna appears to influence pathways associated with both emotional tone and cognitive regulation

Why the Combination Matters

Many products marketed for mood support tend to push physiology in one direction, either toward sedation or toward stimulation.

Kanna’s interaction with both serotonin transport and PDE4 signaling is unusual among botanicals. Rather than simply dampening or activating the nervous system, this dual activity may help explain why some adults describe a state of emotional steadiness alongside clear, engaged thinking.

Users often report feeling less internally reactive, more mentally organized, and more socially present.

The experience is frequently described as calm but alert, not drowsy and not overstimulated.

Three Human Trials That Shaped My View

Nell et al. (2013) , Randomized Double-Blind Trial

A placebo-controlled trial evaluated 25 mg of a standardized kanna extract in healthy adults. Participants demonstrated improvements in specific executive function measures compared with placebo, alongside a favorable tolerability profile.

Chiu et al. (2014) , Functional Neuroimaging Study

In a randomized fMRI investigation, a standardized extract was associated with reduced amygdala reactivity to threat-related stimuli. The study also reported changes in prefrontal cortical activity, suggesting modulation of neural circuits involved in emotional regulation and cognitive processing.

Murbach et al. (2014) , Toxicological Evaluation

Preclinical toxicology assessments reported no evidence of genotoxicity or reproductive toxicity at evaluated doses, supporting the safety of standardized extracts within customary supplemental ranges.

What Adults Commonly Report

Single-Dose Use

Onset may occur within 30-60 minutes depending on route of administration.

Effects are typically described as subtle rather than dramatic, often characterized by reduced internal reactivity, greater social ease, and clearer mental organization.

Many users describe the experience as removing friction rather than creating stimulation.

Repeated Use (Daily, 2+ Weeks)

Some adults report greater emotional steadiness and improved stress resilience with consistent use.

Available human data remain limited, and individual responses vary.

What Kanna Is Not

At typical supplemental doses, kanna is not generally described as sedating or intoxicating.

It is not classified as a stimulant and is not intended to produce euphoric effects.

There is currently no evidence of dependence at customary supplemental levels in available human studies.

Safety & Drug Interactions

Serotonergic Interactions

Because standardized kanna extracts demonstrate activity at the serotonin transporter, caution is warranted when combining with other agents that influence serotonin levels.

Avoid concurrent use with:

• Prescription antidepressants (e.g., SSRIs, SNRIs, MAO inhibitors)
• Certain analgesics such as tramadol
• Triptans
• St. John’s Wort
• 5-HTP or other serotonergic supplements

Combining multiple serotonergic agents carries a theoretical risk of excessive serotonergic activity. Individuals taking prescription medications should consult their physician before use.

Who Should Avoid Use

• Pregnant or breastfeeding individuals
• Those under 18 years of age
• Individuals taking serotonergic medications
• Individuals with significant medical or psychiatric conditions without physician oversight

Potential Side Effects

In available studies and user reports, kanna has generally been well tolerated. Reported effects may include:

• Mild gastrointestinal discomfort
• Transient lightheadedness
• Changes in sleep vividness

Individual responses vary.

How Kanna Compares

FAQ